Evidence map›Paper›PMID 39962474›Full record

ArticleBMC cancer2025

A predictive model for recurrence in patients with borderline ovarian tumor based on neural multi-task logistic regression.

Qiulin Ye, Yue Qi, Juanjuan Liu, Yuexin Hu, Xiao Li, Qian Guo, Danye Zhang, Bei Lin

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiulin YeDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Yue QiDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Juanjuan LiuDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Yuexin HuDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Xiao LiDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Qian GuoDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Danye ZhangDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China.
Bei LinDepartment of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning, 110004, China. linbei88@hotmail.com.

Funding

National Natural Science Foundation of China 82173130National Natural Science Foundation of China 82303503Shenyang Science and Technology Program 22-315-6-16Shenyang Science and Technology Program 22-321-33-19
6 · The paper itself

Abstract

backgroundEffective management of patients with borderline ovarian tumor (BOT) requires the timely identification of those at a higher risk of recurrence. Artificial neural networks have been successfully used in many areas of clinical event prediction, significantly affecting clinical decisions and practice.

objectiveWe developed and validated a novel clinical model based on neural multi-task logistic regression (N-MTLR) for predicting recurrence in patients with BOT who underwent initial surgeries, and compared its prediction performance with that of the Cox regression model.

methodsThis retrospective study included 736 patients diagnosed with BOT from May 2011 to August 2022, with 84 recurrences. The synthetic minority oversampling technique (SMOTE) was used to balance the minority group such that the two patient types were 1:1. Using random sampling, the SMOTE-balanced dataset was divided into 80% of the sample (1043 patients) as the training set and 20% (261 patients) as the validation set. Both N-MTLR and Cox regression models were trained on the training set using SMOTE and evaluated on the validation set using the time-dependent area under the receiver operating characteristic curve (tdAUC), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy.

resultsAmong the 736 enrolled patients, only 84 (11.41%) were diagnosed with BOT recurrence. Using SMOTE, the balanced dataset (1304 patients) contained equal numbers of patients (652 patients) in both recurrence and non-recurrence groups. Multivariate Cox regression analysis of the training set revealed that independent risk factors for BOT recurrence were premenopause, laparoscopic surgery, tumor rupture, advanced clinical stage, undissected lymph nodes, bilateral tumors, and fertility-sparing surgery (FSS). The N-MTLR model was constructed by correlation screening of 34 features in the training set, and 10 variables were screened including FSS, completeness of surgery, comorbidities, International Federation of Gynecology and Obstetrics (FIGO) staging, age, omentectomy, lymphadenectomy, parity, menopausal status, and peritoneal implantation. The N-MTLR model outperformed the Cox regression model in terms of AUC, accuracy, specificity, PPV, and NPV at the quartiles of follow-ups (2, 4, and 7 years).

conclusionsThe N-MTLR model effectively predicts BOT recurrence. Identifying high-risk recurrence groups in patients with BOT can facilitate close monitoring, suitable treatment, and an opportune time for intervention.

Indexed as

Neoplasm Recurrence, LocalNeural Networks, ComputerOvarian NeoplasmsAdultAgedFemaleHumansLogistic ModelsMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesROC CurveBorderline ovarian tumorCox regression modelNeural multi-task logistic regressionRecurrence prediction

Identifiers

PMID39962474
PMCPMC11834230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.